Authors and Disclosures
Author(s)
Michelle L. O'Donoghue, MD, MPH
 |
Senior Investigator, TIMI Study Group; Associate Professor of Medicine, Harvard Medical School; Associate Physician, Brigham and Women's Hospital, Boston, Massachusetts
Disclosure: Michelle L. O'Donoghue, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Novartis; Janssen; CRICO; AstraZeneca; Amgen
Received research grants via Brigham and Women's Hospital from: Amgen; Novartis; AstraZeneca; Janssen; Intarcia; Merck; Pfizer Received honoraria from: Novartis; AstraZeneca; Amgen; Janssen; Medscape
Prior grants from in past 3 years: AstraZeneca (antiplatelet drug ticagrelor); GlaxoSmithKline (anti-inflammatory drugs no longer in development: losmapimod and darapladib); Merck (osteoporosis drug no longer in development: odanacatib); Amgen (osteoporosis drug romosozumab); Janssen (diabetes drug canagliflozin)
Current grants from: Novartis (lipid lowering drug inclisiran); Amgen (lipid lowering drug evolocumab; drug that lowers certain lipoprotein); AstraZeneca/Medimmune (drug that blocks inflammatory receptor)
Consulting: Novartis (lipid-lowering drug); Janssen (education); CRICO AstraZeneca (data safety monitoring board for gout and cardiovascular drug) Amgen (drug that lowers certain lipoprotein)
Honoraria: Medscape Cardiology
The opinions expressed in this article are solely my own and do not necessarily reflect the views and opinions of Brigham and Women's Hospital. |
Robert J. Ostfeld, MD
Professor of Medicine, Albert Einstein College of Medicine; Director of Preventive Cardiology, Montefiore Health System, Bronx, New York
Disclosure: Robert J. Ostfeld, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: BrightPlate; Physician's Committee for Responsible Medicine
Received research grant from: Purjes Foundation; Greenbaum Foundation
Served as a board of director member for: Center for Nutrition Studies
How to Address Social Determinants of Health
How Social Determinants of Health Impact Disparities in IBD Care, Outcomes
Social Determinants of Health May Drive CVD Risk in Black Americans
Agents of Change: 4 Ways to Battle Social Determinants of Health
COMMENTARY
Making Healthy (Plant-Based) Diets the Easy Choice
Michelle L. O'Donoghue, MD, MPH; Robert J. Ostfeld, MD
DisclosuresMay 09, 2022
Join the Top Medical Resource for Physicians Today. Free Membership!
Tables
Authors and Disclosures
Authors and Disclosures
Author(s)
Michelle L. O'Donoghue, MD, MPH
Senior Investigator, TIMI Study Group; Associate Professor of Medicine, Harvard Medical School; Associate Physician, Brigham and Women's Hospital, Boston, Massachusetts
Disclosure: Michelle L. O'Donoghue, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Novartis; Janssen; CRICO; AstraZeneca; Amgen
Received research grants via Brigham and Women's Hospital from: Amgen; Novartis; AstraZeneca; Janssen; Intarcia; Merck; Pfizer Received honoraria from: Novartis; AstraZeneca; Amgen; Janssen; Medscape
Prior grants from in past 3 years: AstraZeneca (antiplatelet drug ticagrelor); GlaxoSmithKline (anti-inflammatory drugs no longer in development: losmapimod and darapladib); Merck (osteoporosis drug no longer in development: odanacatib); Amgen (osteoporosis drug romosozumab); Janssen (diabetes drug canagliflozin)
Current grants from: Novartis (lipid lowering drug inclisiran); Amgen (lipid lowering drug evolocumab; drug that lowers certain lipoprotein); AstraZeneca/Medimmune (drug that blocks inflammatory receptor)
Consulting: Novartis (lipid-lowering drug); Janssen (education); CRICO AstraZeneca (data safety monitoring board for gout and cardiovascular drug) Amgen (drug that lowers certain lipoprotein)
Honoraria: Medscape Cardiology
The opinions expressed in this article are solely my own and do not necessarily reflect the views and opinions of Brigham and Women's Hospital.
Robert J. Ostfeld, MD
Professor of Medicine, Albert Einstein College of Medicine; Director of Preventive Cardiology, Montefiore Health System, Bronx, New York
Disclosure: Robert J. Ostfeld, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: BrightPlate; Physician's Committee for Responsible Medicine
Received research grant from: Purjes Foundation; Greenbaum Foundation
Served as a board of director member for: Center for Nutrition Studies